Insulin Degludec Injection Shortage
Last Updated: June 9, 2025
Status: Current
Products Affected - Description
-
- Insulin Degludec Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 200 units/mL, 3 mL pen injector, 5 count, NDC 73070-0503-15
Reason for the Shortage
-
- Novo Nordisk has insulin degludec on shortage due to a short-term manufacturing delay.
Available Products
-
- Insulin Degludec Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 3 mL pen injector, 5 count, NDC 73070-0403-15
- Tresiba subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, NDC 00169-2662-11
- Tresiba Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 3 mL pen injector, 5 count, NDC 00169-2660-15
- Tresiba Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 200 units/mL, 3 mL pen injector, 5 count, NDC 00169-2550-13
- Insulin degludec subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, NDC 73070-0400-11
Estimated Resupply Dates
-
- Novo Nordisk has insulin degludec 200 units/ mL 3 mL Flextouch pens on allocation.
Updated
Updated June 9, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 13, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.